Back to ICD-10 library
ICD-10-CM · FY 2026 APRIL UPDATE

T46.8X

Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents

Diagnosis reference

Nonbillable category

This entry is a category or subcategory. Choose the appropriate billable descendant based on the clinical documentation.

Effective periodOctober 1, 2026–September 30, 2027
SourceCMS ICD-10-CM order file
ClassificationDiagnosis · clinical modification

Related entries

Up to 30 descendants in this category

CODEDESCRIPTIONTYPE
T46.8X1Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)Category
T46.8X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounterBillable
T46.8X1DPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounterBillable
T46.8X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequelaBillable
T46.8X2Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harmCategory
T46.8X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounterBillable
T46.8X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounterBillable
T46.8X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequelaBillable
T46.8X3Poisoning by antivaricose drugs, including sclerosing agents, assaultCategory
T46.8X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounterBillable
T46.8X3DPoisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounterBillable
T46.8X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequelaBillable
T46.8X4Poisoning by antivaricose drugs, including sclerosing agents, undeterminedCategory
T46.8X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounterBillable
T46.8X4DPoisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounterBillable
T46.8X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequelaBillable
T46.8X5Adverse effect of antivaricose drugs, including sclerosing agentsCategory
T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounterBillable
T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounterBillable
T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequelaBillable
T46.8X6Underdosing of antivaricose drugs, including sclerosing agentsCategory
T46.8X6AUnderdosing of antivaricose drugs, including sclerosing agents, initial encounterBillable
T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounterBillable
T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequelaBillable

Use the complete reference

This reference does not reproduce the full tabular hierarchy, inclusion notes, Excludes1/2 notes, sequencing instructions, or seventh-character rules. Review the official tables and coding guidelines.

Open official CMS files

ICD-10-CM codes describe diagnoses. They do not have an independent Medicare PFS reimbursement amount, and billability alone does not establish coverage.